French orthopedic implants maker Implanet's nine-month revenue jumps, partly on strong US momentum

Implanet SA

13/10/2026 16:55

Overview
France orthopedic implants maker's nine-month 2026 revenue grew 21% yr/yr to €10.6 mln
Q3 2026 revenue rose 18% yr/yr to €3.44 mln
Growth driven by expansion in Spine Implants and Medical Equipment, strong US momentum

Outlook
Company plans to reinforce U.S. commercial team and accelerate rollout of JAZZ and co-developed products
Implanet aims to expand JSS and Sanyou Medical product lines in France, U.S. and internationally
Company to launch SMTP Quntas range and expand distribution of Sanyou Medical surgical technologies

Result Drivers
JSS SYSTEM SALES - Co said doubling sales of new JSS hybrid posterior fixation system boosted Spine Implants revenue
MEDICAL EQUIPMENT - Continued rollout of SMTP ultrasonic scalpel drove Medical Equipment revenue higher
US GROWTH - Co said strong US sales contributed significantly to overall revenue increase

Company press release: ID:nBw3R76Vla

Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
9M Revenue
 
EUR 10.6 mln
 

Reuters Recommended Reads
Oct 12 - France's LVMH nine-month revenue slips amid weak Q3 demand in China

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)